Emerging use of senolytics and senomorphics against aging and chronic diseases

Medicine and Dentistry

• Aging 100%
• Chronic Disease 100%
• Cells 66%
• Development 33%
• Health 33%
• Malignant Neoplasm 33%
• Disease 33%
• Age 33%
• Human 33%
• Liver Disease 33%
• Mechanism of Action 33%
• Wound Healing 33%
• Atherosclerosis 33%
• Maturity Onset Diabetes of the Young 33%
• Lifespan 33%
• Programmed Cell Death 33%
• Senescence 33%
• Osteoarthritis 33%
• Cell Cycle Arrest 33%
• Embryo Development 33%
• Idiopathic Pulmonary Fibrosis 33%
• Quercetin 33%
• Dasatinib 33%
• Fisetin 33%

Biochemistry, Genetics and Molecular Biology

• Aging 100%
• Development 33%
• Apoptosis 33%
• Molecule 33%
• Animal Models 33%
• Quercetin 33%
• Health 33%
• Wound Healing 33%
• Human 33%
• Plant 33%
• Lifespan 33%
• Age 33%
• Senescence 33%
• Embryogenesis 33%
• Cell Cycle Arrest 33%
• Fungus 33%
• Dasatinib 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Chronic Disease 100%
• Animal 33%
• Diseases 33%
• Cell Cycle 33%
• Malignant Neoplasm 33%
• Apoptosis 33%
• Quercetin 33%
• Human 33%
• Plant 33%
• Atherosclerosis 33%
• Wound Healing 33%
• Liver Disease 33%
• Fungus 33%
• Non Insulin Dependent Diabetes Mellitus 33%
• Osteoarthritis 33%
• Fibrosing Alveolitis 33%
• Dasatinib 33%